Aerospace Group:

Homeland Security

Emergent BioSolutions Acquires VaxGen’s Anthrax Vaccine Technology

DDN

Wednesday, May 14th, 2008

SHARE:

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…

Congress

HASC’s Wittman Sees ‘Challenging’ Push For $350B In Reconciliation Funds, Wants Sustained Defense Increase

NATIONAL HARBOR, Md.– Congress’ work to pass $350 billion in reconciliation funds to support the Trump administration’s push for a $1.5 trillion fiscal year 2027 defense topline is “going to […]

Army

Army Secretary Says “We Need To Over-Invest in FLRAA To Get It Online As Quickly As Possible”

Rep. Ken Calvert (R-Calif.), chairman of the House Appropriations Committee’s defense panel (HAC-D), said on Thursday that the Army’s budget plan beginning in fiscal 2027 has more than $2 billion […]

Congress

Pentagon Fiscal 2027 Budget To Address Cannibalization Of Parts For F-35, Legislator Says

The Pentagon’s upcoming fiscal 2027 budget request will help reduce the cannibalization of parts for the F-35 fighter by Lockheed Martin [LMT], the chairman of the House Armed Services Committee’s […]

Budget

Trump’s $1.15 Trillion Request For DoD Is The ‘New Normal,” HASC Chairman Says

COLORADO SPRINGS, Colo.—The Trump administration’s nearly $1.2 trillion baseline defense budget request for fiscal year 2027 will be adopted and will be the foundation for the “new normal” going forward, […]